Johnson & Johnson plans to launch by late September what could become the largest clinical trial of a coronavirus vaccine to date, enlisting up to 60,000 people world-wide to test whether its experimental shot safely protects from Covid-19
Johnson & Johnson plans to launch by late September what could become the largest clinical trial of a coronavirus vaccine to date, enlisting up to 60,000 people world-wide to test whether its experimental shot safely protects from Covid-19.
The targeted enrollment, reported on a government database and confirmed by the company, is double the size of other pivotal studies that have started recently or are expected imminently for vaccines developed by Moderna Inc., Pfizer Inc. and AstraZeneca PLC.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
First Covid-19 vaccine trial moving at a good clip, but officials still 'very concerned'The first coronavirus vaccine trial in the US is moving along at a good clip, but needs more minorities to enroll if it is to succeed, officials tell CNN
Weiterlesen »
Peru to test China Sinopharm's COVID-19 vaccine in Phase 3 trialHealth authorities of the Republic of Peru have approved a Phase 3 clinical trial for a potential COVID-19 vaccine developed by China National Biotec Group (CNBG), the company said on Thursday in Chinese social media platform Weibo.
Weiterlesen »
Australia secures deal for potential Covid-19 vaccine, will provide it free to all citizensAustralia has secured a deal with the drugmaker AstraZeneca to supply a potential Covid-19 vaccine to its entire population free of charge, the government announced Tuesday
Weiterlesen »
Proportion of Brits suffering depression nearly doubles during Covid-19Britain's statistics agency says the rate of depression has jumped from 9.7 percent between July 2019 and March 2020 to 19.2 percent in June 2020.
Weiterlesen »